Bioactive Materials (Aug 2022)

Engineering naphthalimide-cyanine integrated near-infrared dye into ROS-responsive nanohybrids for tumor PDT/PTT/chemotherapy

  • Tongxia Jin,
  • Di Cheng,
  • Guanyu Jiang,
  • Wenqian Xing,
  • Peiwen Liu,
  • Bin Wang,
  • Weiping Zhu,
  • Haitao Sun,
  • Zhenrong Sun,
  • Yufang Xu,
  • Xuhong Qian

Journal volume & issue
Vol. 14
pp. 42 – 51

Abstract

Read online

Photodynamic (PDT) and photothermal therapies (PTT) are emerging treatments for tumour ablation. Organic dyes such as porphyrin, chlorin, phthalocyanine, boron-dipyrromethene and cyanine are the clinically or preclinically used photosensitizer or photothermal agents. Development of structurally diverse near-infrared dyes with long absorption wavelength is of great significance for PDT and PTT. Herein, we report a novel near-infrared dye ML880 with naphthalimide modified cyanine skeleton. The introduction of naphthalimide moiety results in stronger electron delocalization and larger redshift in emission compared with IR820. Furthermore, ML880 is co-loaded with chemotherapeutic drug into ROS-responsive mesoporous organosilica (RMON) to construct nanomedicine NBD&ML@RMON, which exhibits remarkable tumor inhibition effects through PDT/PTT/chemotherapy in vivo.

Keywords